Limberg and Karydakis Flap in Recurrent Pilonidal Sinus Disease

NCT ID: NCT02287935

Last Updated: 2014-11-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

71 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-01-31

Study Completion Date

2014-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It was investigated whether there is a factor that can aid determination of the preferred technique by comparing the early Limberg flap and Karydakis procedure techniques for the treatment of recurrent pilonidal sinus.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Sacrococcygeal pilonidal sinus is common in young men and may recur overtime after surgery.

It was investigated whether there is a factor that can aid determination of the preferred technique by comparing the early Limberg flap and Karydakis procedure techniques for the treatment of recurrent pilonidal sinus.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Recurrent Pilonidal Sinus Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Limberg flap

Patients were divided into two groups, group 1 were treated with Limberg flap technique

Group Type ACTIVE_COMPARATOR

Limberg flap

Intervention Type PROCEDURE

Patients were divided into two groups, group 1 were treated with Limberg flap technique (n= 37) . Two groups were compared with a statistical in terms of fluid collection, wound infection, flap edema, hematoma, partial wound separation, return to daily activities, pain score, completes healing time, painless seating and patient satisfactions

Karydakis procedure

Patients were divided into two groups, group 2 were treated with Karydakis procedure

Group Type ACTIVE_COMPARATOR

Karydakis procedure

Intervention Type PROCEDURE

Patients were divided into two groups, group 2 were treated with Karydakis flap (n= 34). Two groups were compared with a statistical in terms of fluid collection, wound infection, flap edema, hematoma, partial wound separation, return to daily activities, pain score, completes healing time, painless seating and patient satisfactions

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Limberg flap

Patients were divided into two groups, group 1 were treated with Limberg flap technique (n= 37) . Two groups were compared with a statistical in terms of fluid collection, wound infection, flap edema, hematoma, partial wound separation, return to daily activities, pain score, completes healing time, painless seating and patient satisfactions

Intervention Type PROCEDURE

Karydakis procedure

Patients were divided into two groups, group 2 were treated with Karydakis flap (n= 34). Two groups were compared with a statistical in terms of fluid collection, wound infection, flap edema, hematoma, partial wound separation, return to daily activities, pain score, completes healing time, painless seating and patient satisfactions

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients willing to give written informed consent
2. There should be recurrent pilonidal sinus

2\. Recurrent adult patients (over 18 years of age) undergoing surgery for pilonidal sinus

3\. International normalizing ratio (INR) less than 1.5

4\. Prothrombin time (PT) should be less than 15 s

5\. Partial thromboplastin (PTT) time should be near normal

6\. Platelet count should be greater than 50,000 per mm3 to limit the risk of bleeding

7\. There must be no infection at the time of surgery

\-

Exclusion Criteria

1. Patients not willing to give informed consent
2. Age less than 16 years
3. Patient presenting with conditions mimicking pilonidal sinus
4. Diabetes mellitus, renal failure, immunosuppression e.g. were excluded

\-
Minimum Eligible Age

16 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Adana Numune Training and Research Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mehmet Aziret

Doc. Dr. Selim Sözen, A. Prof. Dr. İlhan Bali

Responsibility Role PRINCIPAL_INVESTIGATOR

References

Explore related publications, articles, or registry entries linked to this study.

Bali I, Aziret M, Sozen S, Emir S, Erdem H, Cetinkunar S, Irkorucu O. Effectiveness of Limberg and Karydakis flap in recurrent pilonidal sinus disease. Clinics (Sao Paulo). 2015 May;70(5):350-5. doi: 10.6061/clinics/2015(05)08. Epub 2015 May 1.

Reference Type DERIVED
PMID: 26039952 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AdanaNTRH

Identifier Type: -

Identifier Source: org_study_id